PROMETHEUS BIOSCIENCES, INC. Increase (Decrease) in Accounts Payable
PROMETHEUS BIOSCIENCES, INC. reported Increase (Decrease) in Accounts Payable of $464.00 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2023-05-09
- PROMETHEUS BIOSCIENCES, INC. increase (decrease) in accounts payable for the quarter ending 2023-03-31 was $464.00K, a 37.80% decline year-over-year.
- PROMETHEUS BIOSCIENCES, INC. increase (decrease) in accounts payable for the quarter ending 2022-12-31 was -$223.00K.
- PROMETHEUS BIOSCIENCES, INC. increase (decrease) in accounts payable for the quarter ending 2022-09-30 was $455.00K.
- PROMETHEUS BIOSCIENCES, INC. increase (decrease) in accounts payable for the quarter ending 2022-06-30 was -$1.28M, a 340.64% decline year-over-year.
- PROMETHEUS BIOSCIENCES, INC. increase (decrease) in accounts payable for fiscal 2022 was -$307.00K, a 398.06% decline from fiscal 2021.
- PROMETHEUS BIOSCIENCES, INC. increase (decrease) in accounts payable for fiscal 2021 was $103.00K.
- PROMETHEUS BIOSCIENCES, INC. increase (decrease) in accounts payable for fiscal 2020 was -$480.00K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2023-03-31 | $464.00K 10-Q · filed 2023-05-09 | $241.00K derived: sum of 2 quarters · filed 2023-05-09 | $696.00K derived: sum of 3 quarters · filed 2023-05-09 | -$589.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | -$223.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $232.00K derived: sum of 2 quarters · filed 2023-02-28 | -$1.05M derived: sum of 3 quarters · filed 2023-02-28 | -$307.00K 10-K · filed 2023-02-28 |
| 2022-09-30 | $455.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$830.00K derived: sum of 2 quarters · filed 2022-11-09 | -$84.00K 10-Q · filed 2022-11-09 | -$599.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-06-30 | -$1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$539.00K 10-Q · filed 2022-08-11 | -$1.05M derived: sum of 3 quarters · filed 2023-05-09 | -$1.58M derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-03-31 | $746.00K 10-Q · filed 2023-05-09 | $231.00K derived: sum of 2 quarters · filed 2023-05-09 | -$294.00K derived: sum of 3 quarters · filed 2023-05-09 | $240.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$515.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$1.04M derived: sum of 2 quarters · filed 2023-02-28 | -$506.00K derived: sum of 3 quarters · filed 2023-02-28 | $103.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | -$525.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $9.00K derived: sum of 2 quarters · filed 2022-11-09 | $618.00K 10-Q · filed 2022-11-09 | $1.35M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $534.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $1.14M 10-Q · filed 2022-08-11 | $1.87M derived: sum of 3 quarters · filed 2023-02-28 | $1.10M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $609.00K 10-Q · filed 2022-05-12 | $1.34M derived: sum of 2 quarters · filed 2023-02-28 | $571.00K derived: sum of 3 quarters · filed 2023-02-28 | -$60.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $730.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$38.00K derived: sum of 2 quarters · filed 2023-02-28 | -$669.00K derived: sum of 3 quarters · filed 2023-02-28 | -$480.00K 10-K · filed 2023-02-28 |
| 2020-09-30 | -$768.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$1.40M derived: sum of 2 quarters · filed 2021-11-12 | -$1.21M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | -$631.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$442.00K 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | $189.00K 10-Q · filed 2021-05-13 |